DC646 treatment significantly lowered the serum alanine aminotransferase (ALT) level to a similar extent as GUDCA, whereas OCA cannot improve the serum transferase level in the MCD diet-induced MASH model (Fig. 5g). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.